DNAmedicatiepas


Available genetic information from extensive DNA analysis was barely being applied in the everyday healthcare process for individualised pharmacogenetic advice, but this valuable information is now available via the DNAmedicatiepas. The pass is an easy way for patients, physicians and pharmacists to verify whether the genetic profile of the individual patient is being taken into account. The pass is intended to reduce side eff ects and speed up the process of finding the right drug and dosage. The DNAmedicatiepas connects personal genetic information, based on whole exome sequencing (WES), with current Dutch medication recommendations. The personal pass has a QR code that contains the relevant genetic variants of the patient. The pharmacist or physician scan the pass to see whether the prescription needs to be adjusted based on the genetic profile.

Target population
Not specified or other
Development Year
2021
Aandoeningscategorie
NA or Not specified
Get going

Characteristics

Edition
Healthcare Enablers 2021
Amsterdam UMC, Leids Universitair Medisch Centrum, Z-Index
Trend
Enhanced Diagnostics
Sector
Cross-domain
Aim
(Health) Information exchange between care provider - patient
Phase
Diagnosis
Technology type
Genomics
Other
Conditionion
NA or not specified